Bleakley Financial Group »

Edgewise Therapeutics shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $264k 9.9k 26.69
2024-06-30 $275k 15k 18.01

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Sprott Physical Gold & Silve Tr Unit (CEF)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
NVIDIA Corporation (NVDA)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Malvern Fds Strm Infproidx (VTIP)

View all positions for Bleakley Financial Group

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
BlackRock
BlackRock
Baker Bros. Advisors
Novo A/S
Vanguard Group
Cormorant Asset Management
Frazier Life Sciences Management
Paradigm Biocapital Advisors
Henderson Group
Perceptive Advisors
TCG Crossover Management
Braidwell
Driehaus Capital Management

View all funds holding Edgewise Therapeutics